RecallDepth
Class II Ongoing

Admelog, insulin lispro injection, 100 units/mL (U-100), 3mL multi-dose vial, Rx Only, Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807 A Sanofi Company. NDC 0024-5926-05

Company
Sanofi-Aventis U.S. Llc
Recall Initiated
April 11, 2023
Posted
May 24, 2023
Recall Number
D-0575-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
51,325 vials
Firm Location
Bridgewater, NJ, United States

Reason for Recall

Lack of Assurance of Sterility: Malformed crimped collar seal

Distribution

Nationwide in the USA

Lot / Code Info

Lot # 3F497B, EXP 12-31-2025

More recalls by Sanofi-Aventis U.S. Llc

View all recalls by this company →

Other recent Class II Drug recalls